Residual Beta Cell Function in Newly Diagnosed Type 1 Diabetes after Treatment with Atorvastatin: The Randomized DIATOR Trial
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference36 articles.
1. Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group.;Diabetes,1988
2. Advances in Type 1 diabetes therapeutics: immunomodulation and beta-cell salvage.;F Waldron-Lynch;Endocrinol Metab Clin North Am,2009
3. Atorvastatin inhibits T cell activation through 3-hydroxy-3-methylglutaryl coenzyme A reductase without decreasing cholesterol synthesis.;N Blank;J Immunol,2007
4. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.;J Bonnet;Clin Ther,2008
5. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site.;G Weitz-Schmidt;Nat Med,2001
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review;Communications Medicine;2023-10-05
2. Effect of verapamil on pancreatic beta cell function in newly diagnosed type 1 diabetes in children;Die Diabetologie;2023-04-30
3. Type 1 Diabetes Prevention: a systematic review of studies testing disease-modifying therapies and features linked to treatment response;2023-04-17
4. Effect of atorvastatin on testosterone levels;Cochrane Database of Systematic Reviews;2021-01-22
5. Influence of Statins on Circulating Inflammatory Cytokines in Patients With Abnormal Glucose Homeostasis: A Meta-analysis of Data From Randomized Controlled Trials;Clinical Therapeutics;2020-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3